PDS Biotechnology Corporation is a clinical-stage immunotherapy company focused on developing novel cancer treatments. Its proprietary Versamune platform is designed to enable the body’s immune system to recognize and destroy tumor cells. With several promising clinical trials underway, PDS Biotechnology is rapidly advancing its pipeline of innovative cancer therapies.
